The blockbuster cancer drug Keytruda can cost over $150,000 | The Excerpt
April 15, 2026
456
21
5
5.70%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
USA Today Episodes Around April 15, 2026
See what was published immediately before and after this episode.
11:01Now PlayingThe blockbuster cancer drug Keytruda can cost over $150,000 | The Excerpt
YouTube Description
as posted by the channelLast December, President Donald Trump convened a meeting of pharmaceutical executives with the goal of getting them to lower the cost of prescription drugs. A few weeks later, one patient battling lung cancer checked into a California clinic for an infusion of Merck & Co.'s blockbuster cancer drug, Keytruda. When the bill arrived, the clinic's charge for a 400 mg dose dominated the page: It was just over $162,000. While Brown only owed about $2,000 herself, the six-figure charges show how quickly prices for cutting-edge medical treatments can balloon in the U.S. health care system. USA TODAY joined the International Consortium of Investigative Journalists in their year-long, reporting effort looking into rising healthcare costs around the world. USA TODAY Health Reporter Ken Alltucker joined The Excerpt to share his insights.
Sign up for our newsletter for the day's top stories, from sports to movies to politics to world events
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.